Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

161
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
161
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

124
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
124
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

135
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
135
Drug Nomenclature01:17

Drug Nomenclature

2.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.8K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

449
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
449
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

152
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent infections caused by ESBL-producing enterobacterales with or without subsequent development of distinct carbapenem-resistant phenotypes: differential driving factors and impact on outcome.

JAC-antimicrobial resistance·2026
Same author

Evaluation of a community health worker certification program and participants' self-assessed preparedness.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Change in student pharmacist perceived competency in pharmacists' patient care process, electronic health record, and drug information skills: A cross-sectional study.

Currents in pharmacy teaching & learning·2026
Same author

A Real-world Study Evaluating the Clinical Factors Associated with the Initial SGLT2 Inhibitor Prescription.

Journal of health care for the poor and underserved·2024
Same author

Temporal Dynamics of Host Immune Response Associated With Disease Severity and Time to Recovery in Patients Hospitalized for COVID-19.

Critical care explorations·2024
Same author

Machine learning to identify risk factors associated with the development of ventilated hospital-acquired pneumonia and mortality: implications for antibiotic therapy selection.

Frontiers in medicine·2024

Related Experiment Video

Updated: Jan 3, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Do pharmacist employers prefer or require board certification?

Fay Goldenshteyn, Julie Dopheide, Mimi Lou

    Journal of the American Pharmacists Association : Japha
    |November 20, 2019
    PubMed
    Summary

    Most pharmacy employers do not require or prefer board certification. However, clinical roles are more likely to prefer or require board certification, with pharmacotherapy being the most requested specialty.

    More Related Videos

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    4.3K
    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
    07:02

    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

    Published on: February 11, 2019

    10.2K

    Related Experiment Videos

    Last Updated: Jan 3, 2026

    A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
    07:31

    A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

    Published on: February 13, 2020

    7.3K
    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    4.3K
    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
    07:02

    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

    Published on: February 11, 2019

    10.2K

    Area of Science:

    • Pharmacy Practice
    • Healthcare Employment Trends
    • Professional Certification

    Background:

    • The pharmacy profession advocates for board certification, but its effect on pharmacist employment is unclear.
    • This study investigates employer demand for board certification in pharmacy job listings.

    Purpose of the Study:

    • To assess employer requirements and preferences for board certification in pharmacy job postings.
    • To analyze the relationship between job type (clinical vs. non-clinical) and board certification.
    • To identify preferred specialties and employer rationale for requiring/preferring certification.

    Main Methods:

    • A national search of pharmacy job postings (Nov 2018–Mar 2019) was conducted.
    • Data collected included certification status (required/preferred/neither), specialty, and practice setting.
    • Employers were surveyed about their reasons for certification preferences.

    Main Results:

    • Nearly equal numbers of employers did not prefer/require certification (51%) versus those who did (49%).
    • Clinical pharmacy positions were significantly more likely to require or prefer board certification (53%) compared to non-clinical roles (27%).
    • Pharmacotherapy, oncology, and psychiatry were the most frequently requested board certifications. Employers believe certification verifies competence and specialized knowledge.

    Conclusions:

    • A slight majority of pharmacy employers do not mandate or prefer board certification.
    • Board certification is more frequently preferred or required for predominantly clinical pharmacy positions.